Okamura; Haruki

Patent Applications and Registrations

Patent applications and USPTO patent grants for Okamura; Haruki.The latest application filed is for "therapeutic agent for cancer which comprises combination of il-18 and molecule-targeting antibody".

Company Profile

0.15.5

Okamura; Haruki - Hyogo JP
OKAMURA; Haruki - Osaka JP
Okamura; Haruki - Ibaraki JP
Okamura; Haruki - Ibaraki-shi JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Therapeutic agent for cancer which comprises combination of IL-18 and molecule-targeting antibody Grant 11,219,672 - Okamura , et al. January 11, 2	2022-01-11
Therapeutic Agent For Cancer Which Comprises Combination Of Il-18 And Molecule-targeting Antibody App 20170224791 - OKAMURA; Haruki ; et al.	2017-08-10
Monoclonal Antibody Against Interferon-gamma (ifn-gamma) Inducing Factor (ifig, Il-18) App 20140336364 - OKAMURA; Haruki ; et al.	2014-11-13
IFN-.gamma. production inducing protein (IGIF, IL-18) Grant 7,758,853 - Okamura , et al. July 20, 2	2010-07-20
V.gamma.9V.delta.2 T cell proliferation agent, method for producing activated V.gamma.9V.delta.2 T cells, and uses thereof Grant 7,749,760 - Okamura , et al. July 6, 2	2010-07-06
Method For Preventing Or Treating Cisplatin-induced Nephrotoxicity App 20100035853 - UEDA; Haruyasu ; et al.	2010-02-11
Vgamma9Vdelta2 T cell proliferation agent, method for producing activated Vgamma9Vdelta2 T cells, and uses thereof App 20100009447 - Okamura; Haruki ; et al.	2010-01-14
Interferon-.gamma. inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use Grant 7,355,014 - Ushio , et al. April 8, 2	2008-04-08
Interferon-gamma inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use App 20070031403 - Ushio; Shimpei ; et al.	2007-02-08
Interferon-.gamma. inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use Grant 7,135,458 - Ushio , et al. November 14, 2	2006-11-14
DNA molecule encoding interferon-gamma (IFN-.lambda.) inducing factor (IGIF, IL-18) and DNA fragment thereof Grant 6,277,598 - Okamura , et al. August 21, 2	2001-08-21
Human Interferon-.gamma.inducing factor Grant 6,214,584 - Ushio , et al. April 10, 2	2001-04-10
Recombinant production of murine interferon--.gamma. (IFN-.gamma.) inducing factor (IGIF, IL-18) Grant 5,914,253 - Okamura , et al. June 22, 1	1999-06-22
Interferon-gamma (IFN-.gamma.) inducing factor (IGIF, IL-18) purified from murine liver Grant 5,912,324 - Okamura , et al. June 15, 1	1999-06-15
Thermally stabilized butadiene resins containing a hindered phenolic acrylate or methacrylate Grant 4,774,274 - Takata , et al. September 27, 1	1988-09-27
Purification of hydroxyphenylpropionic acid ester Grant 4,739,080 - Sasaki , et al. April 19, 1	1988-04-19
Stabilized polyurethane compositions Grant 4,721,744 - Ishii , et al. * January 26, 1	1988-01-26
Stabilized polyacetal resin compositions Grant 4,717,745 - Ishii , et al. * January 5, 1	1988-01-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.